Gerard Kelly MD MEd FRCS (ORL-HNS) FRCS (Ed) ENT surgeon, Leeds
description
Transcript of Gerard Kelly MD MEd FRCS (ORL-HNS) FRCS (Ed) ENT surgeon, Leeds
Gerard Kelly MD MEd FRCS (ORL-HNS) FRCS (Ed)ENT surgeon, Leeds
6th March 2014, Leeds Masonic Hall
ENT
The
Leed
s Te
achi
ng
Hos
pita
ls N
HS
Tru
st
and general practice
my nose is blocked – an update on rhinosinusitis & snoring
aimsgive an overview of common (E)N(T)
conditionsshows some example casesrefine our thinking of ENT problems
objectiveslist the main symptoms in nose conditionsrelate each symptom to one conditionlist the ways to examine the noseidentify an nasal polypclassify rhinosinusitislist 6 treatments for chronic rhinosinusitis
(CRS)define association with CRS & respiratory
diseaselist treatments for nasal polyps formulate a management plan for snoring
first though...history and examination in ENT
Allergic Rhinitis Epidemiology
Allergic rhinitis is the most common form of non-infectious rhinitis
At least 500 million individuals world-wide have allergic rhinitis and it is one of the most common reasons for attendance with a primary care practitioner
Almost 30% of adults and 40% of children are affected
World-wide the prevalence of allergic rhinitis continues to increase UK/FF/0108/11 April 2011
References1. Bousquet J et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 2008;63 Suppl 86:8-1602. Wallace DC et. J Allergy Clin Immunol 2008; 122: S1-84
Allergic Rhinitis Classification
BSACI GuidelinesSeasonal (UK)Tree pollen (birch, plane, ash + hazel)Grass pollen (timothy, rye + cocksfoot)Weed pollen ( mugwort + nettle)Fungal spores ( Cladosporium spp,Alternaria spp + Aspergilus spp)
Perennial (UK)House dust mite (Dermatophagoides pteronyssinus) + Animal Dander
Occupational Flour, grain, latex, wood dust, detergents
UK/FF/0108/11 April 2011
British society for allergy and clinical
immunology
Diagnosis of allergic rhinitis
Intermittent symptomsMild
oral antihistamineorintranasal antihistamine+/- decongestantor leukotriene antagonist
Asthma?
Moderate
oral antihistamineorintranasal antihistamine+/- decongestantor topical nasal steroidorleukotriene antagonistorcromogycate
consider
Diagnosis of allergic rhinitis
Persistent symptoms
Asthma?
Mild
oral antihistamineorintranasal antihistamine+/- decongestantor topical nasal steroidorleukotriene antagonistorcromogycate
consider
Diagnosis of allergic rhinitis
Persistent symptoms
Asthma?
Moderate severe
topical nasal steroid
oral antihistamineorleukotriene antagonist
Review after 2 -4 weeks
If better, step down and continue for > 1 month
consider
Diagnosis of allergic rhinitis
Persistent symptoms
Asthma?
Moderate severe
topical nasal steroid
oral antihistamineorleukotriene antagonist
Review after 2 -4 weeks
If not better, review diagnosisreview compliancequery infective / other cause
increase nasal steroidipratropium (rhinorrhoea)decongestant or oral steroid (blockage)
consider
Diagnosis of allergic rhinitis
Persistent symptoms
Asthma?
Moderate severe
topical nasal steroid
oral antihistamineorleukotriene antagonist
Review after 2 -4 weeks
If not better, review diagnosisreview compliancequery infective / other cause
increase nasal steroidipratropium (rhinorrhoea)decongestant or oral steroid (blockage)
If not better, refer
consider
Common co-morbidities: Asthma Approximately 80% of asthmatics have rhinitis
Allergic rhinitis may precede asthma
Rhinitis impairs asthma control
Treatment of allergic rhinitis may improve asthma control
Allergic Rhinitis and its Impact in Asthma (ARIA) promotes assessing everyone with allergic rhinitis for asthma
UK/FF/0108/11 April 2011
References1. Bousquet J et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 2008;63 Suppl 86:8-1602. Wallace DC et. J Allergy Clin Immunol 2008; 122: S1-84
Common co-morbidities: Rhinoconjunctivitis
IncidenceOcular symptoms are commonRhinoconjunctivitis symptoms have
been reported in more than 75% of patients with seasonal allergic rhinitis
Clinical significanceSeverely impairs QOLOften a forgotten aspect of care
UK/FF/0108/11 April 2011
Reference1. Wallace DC et al. J Allergy Clin Immunol 2008; 122: S1-84
Allergen AvoidanceBackgroundSuccess of intervention measured by clinical
improvementStrategy success influenced by individual
host sensitivity to allergenSensitivity differs betweens allergens EffectivenessStudies do not show consistent reduction in symptoms or medication requirements
UK/FF/0108/11 April 2011
Reference:1.Scadding GK et al. Clin Exp Allergy 2008; 38:19-42
allergen avoidancemattress, pillow, duvet coverssynthetic duvets, pillowsavoid woollen blanketsvacuum frequentlyavoid carpets, curtainskeep clothing in cupboardskeep animals out of bedroomslow relative humidityboil wash sheet, duvet covers
Nasal Decongestants (oral/topical)
BackgroundRelieve nasal congestionCause nasal vasoconstriction and decreased
oedemaTopical - risk of rhinitis medicamentosa Side effectsOral - Hypertension
Caution with caffeine &other stimulants
Topical - Local stinging/burningNasal drynessSneezing
UK/FF/0108/11 April 2011
References1. Wallace DC et. J Allergy Clin Immunol 2008; 122: S1-84
Oral Antihistamines
Seasonal and perennial allergic rhinitis
BSACI guidelines state that regular therapy is more effective than ‘as needed use’ in persistent rhinitis
Reduce sneezing, rhinorrhoea and nasal and ocular pruritis but have less effect on nasal congestion
ARIA recommend 2nd generation formulations which cause less sedation
UK/FF/0108/11 April 2011
References1. Scadding GK et al. Clin Exp Allergy 2008; 38: 19-422. Dykewicz MS. J Allergy Clin Immunol 2003; 111: S520-93. Bousquet J et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 2008;63 Suppl 86:8-160
Intranasal Steroids
ARIA guidelines state that intranasal steroids are the most effective drugs for the treatment of allergic rhinitis
Effective in relieving nasal congestion, rhinorrhoea, sneezing and nasal itching
Grade A level of recommendation for seasonal and perennial allergic rhinitis
Recommended to be administered regularly for optimal benefit
UK/FF/0108/11 April 2011
References:1. Bousquet J et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 2008;63 Suppl 86:8-1602. Rosenwasser LJ. Am J Med 2002; 113 (9A) 17S-24S3. Scadding GK et al. Clin Exp Allergy 2008; 38: 19-42
Intra-nasal steroids
Local Side-effectsNasal irritation (propylene glycol/ benzalkonium
chloride)Nasal bleeding/crustingSeptal perforation (rare – advise to use device away
from septum)
Warn patientsAvoidance with correct delivery techniqueMay be related to device induced traumaNo evidence of nasal tissue atrophy
UK/FF/0108/11 April 2011
Intra-nasal steroids - systemic side effects
Minimal absorption from nasal mucosaUp to 80% of intranasal dose swallowed
Extensive hepatic first-pass metabolism by cytochrome P450 system
Minimal systemic levelsNo significant HPA suppression or effects on growth
Second generation INS
References1. LaForce. J Allergy Clin Immunol 1999; 103: S388-96
Summary
Allergic rhinitis is a common disease with a significant clinical and socioeconomic impact
Accurate diagnosis and focussed therapeutic intervention is essential
Important to diagnose and treat any associated co-morbidities
Address factors that improve patient tolerability and compliance with therapy
UK/FF/0108/11 April 2011
snoring
common
snoring
directly related to collar size
snoring
BMIevening alcoholmale
snoring treatments
weight reductionpositionstopping evening alcoholCPAPMADsurgery
snoring treatments
surgery
tonsillectomy, nasal polypectomyLAUPU3Psclerosant injectioncoblation, radiofrequency somnoplastypillar implants
Nasal septal perforationsurgerytraumacocaine useinfection
post trauma, syphilisWegener’s granulomatosissarcoidosisidiopathic